Table 3 Expression of CK7, CK20, and CDX2 in cancer tissues by histopathological characteristics
| Â | CK7+ | CK20+ | CDX2+ | |||
|---|---|---|---|---|---|---|
| Â | n | % | n | % | n | % |
Colorectal adenocarcinoma (n = 118) | Â | Â | Â | Â | Â | Â |
   Low grade (n = 96) | 22 | 22.9 | 87 | 90.6 * | 94 | 97.9 |
   High grade (n = 22) | 4 | 18.2 | 12 | 54.5 * | 20 | 90.9 |
   Rectal (n = 85) | 18 | 21.2 | 76 | 89.4§ | 83 | 97.6 |
   Nonrectal (n = 33) | 8 | 24.2 | 23 | 69.7§ | 31 | 93.9 |
Gastric adenocarcinoma (n = 59) | Â | Â | Â | Â | Â | Â |
   Intestinal type (n = 30) | 21 | 70.0 | 16 | 53.3 | 23 | 76.7 # |
   Diffuse type (n = 29) | 26 | 89.7 | 15 | 51.7 | 13 | 44.8 # |
Pancreatic adenocarcinoma (n = 32) | Â | Â | Â | Â | Â | Â |
   Low grade (n = 30) | 30 | 100.0 | 7 | 23.3 | 5 | 16.7 |
   High grade (n = 2) | 1 | 50.0 | 0 | 0.0 | 0 | 0.0 |